Q5C-32763-57586
4 vaccinations
2 coded responses
50 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-11-02
Dose 3 — Pfizer-BioNTech
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-11
-
2021-11-16
Survey response — day 14, dose 3MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had a miscarriage followed by a D&C.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-19
- 2021-11-23
- 2021-11-30
- 2021-12-08
- 2021-12-16
- 2022-02-03
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
-
2022-09-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache · Be unable to work or attend schoolAdult check-in
- 2022-09-24
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-23
- 2022-10-31
- 2022-12-19
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-16 | Unsuccessful |
Free text
Release 10 — day 14, dose 3
Symptoms: Had a miscarriage followed by a D&C.
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release